STEVEN ARNOLD: Open Payments
NPI 1629243530 · MCCOMB, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 32 payments from 10 companies in 2025. Trend: 2023 $401 · 2024 $179 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 15 | $181 |
| ABIOMED | 7 | $152 |
| SCPHARMACEUTICALS INC. | 2 | $45 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: GALLANT, FUROSCIX, LifeVest, ASSURITY, Kerendia, JOT DX, CARDIOMEMS, VERQUVO.
Industry payments across MS — which companies pay providers there.
